NZM2
vs
D
DAX Index
NZM2
Over the past 12 months, NZM2 has underperformed DAX Index, delivering a return of -14% compared to the DAX Index's +3% growth.
Stocks Performance
NZM2 vs DAX Index
Performance Gap
NZM2 vs DAX Index
Performance By Year
NZM2 vs DAX Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Novozymes A/S
Glance View
Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly. The company’s extensive portfolio of enzymes transforms processes across a diverse array of industries, including agriculture, food and beverages, household care, and bioenergy. By engineering microorganisms to optimize yield and reduce waste, Novozymes provides solutions that both enhance product performance and support environmental goals. Revenue generation for Novozymes predominantly stems from its ability to innovate and provide proprietary solutions that businesses around the world rely on to gain a competitive edge. While enzymes in detergents simplify stain removal and enable energy-efficient washing at lower temperatures, in agriculture, Novozymes' biological solutions enhance crop yield by fostering nutrient absorption and pest resilience. This vast spectrum of applications showcases the company's deep integration into its clients' production processes, creating a stable demand. Novozymes capitalizes on its research and development prowess, ensuring a continuous flow of advanced, tailor-made bio-solutions, thereby securing long-term partnerships and a sustainable revenue stream from its global market presence.
